Home

Glenmark Life Sciences Ltd PE Ratio

Image

Glenmark Life Sciences Ltd

NSE: GLS

PE

29.5

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Glenmark Life Sciences Ltd is 29.5 as of 15 Jan 9.00 AM .
  • The P/E Ratio of Glenmark Life Sciences Ltd changed from 13.4 on March 2022 to 20.2 on March 2024 . This represents a CAGR of 14.66% over 3 years.
  • The Latest Trading Price of Glenmark Life Sciences Ltd is ₹ 1020 as of 14 Jan 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Glenmark Life Sciences Ltd

No data available

Company Fundamentals for Glenmark Life Sciences Ltd

Image

Glenmark Life Sciences Ltd

NSE: GLS

Share Price

₹ 1020.8

36.30 (3.69%)

stock direction

Last updated on: Jan 14, 2025

Market Price of Glenmark Life Sciences Ltd

1M

1Y

3Y

5Y

Monitoring Glenmark Life Sciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 20251020.8
13 Jan 2025984.5
10 Jan 20251011.1
09 Jan 20251029.35
08 Jan 20251041.7
07 Jan 20251041.15
06 Jan 20251003.6
03 Jan 20251029.65
02 Jan 20251029.65
01 Jan 20251016.35

SWOT Analysis Of Glenmark Life Sciences Ltd

Strength

2

che

Weakness

2

che

Opportunity

1

che

Threats

0

che

BlinkX Score for Glenmark Life Sciences Ltd

Asset Value vs Market Value of Glenmark Life Sciences Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Glenmark Life Sciences Ltd12508
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of Glenmark Life Sciences Ltd Explained

``

12508

Market cap

423

Earnings

29.5X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Glenmark Life Sciences Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Glenmark Life Sciences Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Glenmark Life Sciences Ltd

No data available

* All values are in %

About Glenmark Life Sciences Ltd

  • Glenmark Life Sciences Limited was incorporated as Zorg Laboratories Private Limited', on June 23, 2011 at Pune and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra at Pune.
  • Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences Private Limited' dated 10 August 2018.
  • A shareholders' resolution was passed on 13 August 2018 to convert the Company from a Private Limited Company to a Public Limited Company and a fresh Certificate of Incorporation dated 28 August 2018 was issued by the RoC. The Company is a wholly owned Subsidiary of Glenmark Pharmaceuticals Limited.
  • The Company acquired API Division of Glenmark Pharmaceuticals Limited (the parent company) on 01 January, 2019.

Glenmark Life Sciences Ltd News Hub

Glenmark Life Sciences Ltd leads gainers in 'A' group

Tamilnad Mercantile Bank Ltd, Marico Ltd, Rossari Biotech Ltd and Nestle India Ltd are among the oth

Read more

2024-08-05 00:00:00

Glenmark Life Sciences AGM scheduled

Glenmark Life Sciences announced that the Annual General Meeting (AGM) of the company will be held o

Read more

2024-09-06 00:00:00

Glenmark Life drops after PAT slides 20% YoY to Rs 95 crore in Q2

Profit before tax (PBT) dropped 19.8% YoY to Rs 127.46 crore in the quarter ended 30 September 2024.

Read more

2024-10-25 00:00:00

Glenmark Life Sciences standalone net profit declines 19.72% in the September 2024 quarter

Net profit of Glenmark Life Sciences declined 19.72% to Rs 95.32 crore in the quarter ended Septembe

Read more

2024-10-25 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Glenmark Life Sciences Ltd

What is the current PE Ratio of Glenmark Life Sciences Ltd?

The Current PE Ratio of Glenmark Life Sciences Ltd is 29.54 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Glenmark Life Sciences Ltd last year?

The PE Ratio of Glenmark Life Sciences Ltd was 10.28 last year, now the PE ratio is 29.54, showing a year-on-year growth of 187.4%.

What does the PE Ratio of Glenmark Life Sciences Ltd indicate about its stock?

The PE Ratio of Glenmark Life Sciences Ltd is 29.54. This ratio indicates that investors are willing to pay 29.54 times the earnings per share for each share of Glenmark Life Sciences Ltd.

What is the PE Ratio Growth of Glenmark Life Sciences Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Glenmark Life Sciences Ltd grew by 187.4% whereas, the EPS ratio grew by -14.5.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions